InMode Ltd.INMDNASDAQ

Overview Intelligence Charts News Fundamentals Key Metrics Financials Growth Insiders

Latest News

prnewswire.com

InMode to Present at Upcoming Investor Conferences

YOKNEAM, Israel, Feb. 26, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation at the following investor conferences in March: Barclays 28th Annual Global Healthcare Conference Presenters: Yair Malca, Chief Financial Officer Format: In-person fireside chat moderated by Matt Miksic, Senior Equity Analyst, and one-on-one meetings Location: Miami, FL When: Wednesday, March 11 at 12:30 pm ET A live webcast of the presentation can be accessed here.

benzinga.com

InMode (INMD) Stock Slips As Board Ends Review

The committee, formed by InMode's board, evaluated multiple proposals for a potential transaction with help from outside financial and legal advisers. After reviewing the final bids, it concluded that none were adequate or in the best interests of the company and its shareholders, and decided to discontinue the process.

prnewswire.com

InMode Announces Conclusion of Independent Transaction Committee Review

YOKNEAM, Israel, Feb. 23, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) a leading global provider of innovative medical technologies ("InMode" or the "Company"), today announced that the independent transaction committee of its Board of Directors (the "Committee") has completed its review of proposals received in connection with a potential transaction.

seekingalpha.com

InMode: Some Green Shoots Appearing, But The Market Hasn't Noticed

InMode Ltd. remains a Strong Buy at current levels, supported by a robust balance sheet, proprietary technology, and international growth. Green shoots include a 2.7% rise in consumables/servicing revenue and 14.5% international sales growth, offsetting possible U.S. market saturation. Management guides for flat 2026 revenue, with new product launches and expanding international footprint positioning INMD for future upside.

seekingalpha.com

InMode Ltd. (INMD) Q4 2025 Earnings Call Transcript

prnewswire.com

InMode Reports Fourth Quarter and Full Year 2025 Financial Results: Quarterly GAAP Revenue of $103.9 Million and Full Year Revenue of $370.5 Million

YOKNEAM, Israel, Feb. 10, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the fourth quarter and full year of 2025.

defenseworld.net

New York State Common Retirement Fund Has $1.27 Million Stock Position in InMode Ltd. $INMD

New York State Common Retirement Fund raised its stake in InMode Ltd. (NASDAQ: INMD) by 355.9% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 85,062 shares of the healthcare company's stock after acquiring an additional 66,402 shares during the period. New

prnewswire.com

InMode to Participate in the 13th Annual BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference

YOKNEAM, Israel, Feb. 3, 2026 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced that Yair Malca, Chief Financial Officer will host investor meetings at the BTIG MedTech, Digital Health, Life Sciences & Diagnostics Tools Conference in Snowbird, UT on Wednesday, February 11, 2026.

prnewswire.com

InMode Responds to Transaction Rumors

YOKNEAM, Israel, Feb. 2, 2026 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies ("InMode" or the "Company"), today issued the following statement: The Company is aware of recent market speculation and rumors, including reports relating to the publicly announced non-binding proposal by Steel Partners Holdings L.P.

benzinga.com

Steel Partners Targets InMode, Citing Stock Underperformance

Steel Partners Holdings on Wednesday publicly disclosed an unsolicited proposal to acquire a controlling stake in InMode Ltd. (NASDAQ: INMD), offering shareholders a cash premium while criticizing the company's stock performance, capital allocation, and repeated guidance cuts.

businesswire.com

Steel Partners Holdings L.P. Announces It Has Presented $18.00 Per Share Offer for 51% of InMode Ltd.

NEW YORK--(BUSINESS WIRE)--Steel Partners Holdings L.P. (together with its affiliates, “Steel”), which beneficially owns approximately 1.3% of the outstanding shares of InMode Ltd. (Nasdaq: INMD) (“InMode” or the “Company”), today issued a public letter to the Company's shareholders. The full text of the letter is below. January 28, 2026 Fellow Shareholders, We are writing to make you aware that we have expressed interest to InMode's leadership in pursuing an acquisition by Steel Partners of 51.

investors.com

InMode Flies To Three-Month High On A Rumored $1.1 Billion Takeover Offer

A foreign investment fund could scoop up medical aesthetics outlet InMode for $1.1 billion, an analyst said Monday as InMode stock surged.

defenseworld.net

Jushi (OTCMKTS:JUSHF) versus InMode (NASDAQ:INMD) Head-To-Head Survey

InMode (NASDAQ: INMD - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Valuation and Earnings This table compares InMode and Jushi"s

prnewswire.com

InMode to Report Fourth Quarter & Full Year 2025 Financial Results and Hold Conference Call on February 10, 2026, Expects Q4 Revenue Between $103.6M-$103.8M

Conference call to be held on Tuesday, February 10, 2026, at 8:30 a.m. Eastern Time YOKNEAM, Israel, Jan. 8, 2026 /PRNewswire/ -- InMode Ltd.

seekingalpha.com

InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In

InMode Ltd. remains a global leader in minimally invasive aesthetic medical devices, trading at a deep discount with a net cash position covering 58% of market cap. Despite a sharp 85% drawdown since 2021, INMD's robust balance sheet, strong FCF generation, and signs of improving fundamentals support a reiterated strong buy rating. Operational challenges—declining margins, inventory build, and sales execution—are offset by aggressive buybacks, high FCF yield, and significant upside if management improves capital allocation.

defenseworld.net

InMode Ltd. $INMD Shares Sold by Acadian Asset Management LLC

Acadian Asset Management LLC lessened its holdings in InMode Ltd. (NASDAQ: INMD) by 40.6% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 330,443 shares of the healthcare company's stock after selling 225,970 shares during the period. Acadian Asset Management LLC owned

seekingalpha.com

InMode Ltd. (INMD) Q3 2025 Earnings Call Transcript

InMode Ltd. ( INMD ) Q3 2025 Earnings Call November 5, 2025 8:30 AM EST Company Participants Moshe Mizrahy - Co-Founder, CEO & Director Yair Malca - Chief Financial Officer Conference Call Participants Miri Segal-Scharia - MS-IR LLC Danielle Antalffy - UBS Investment Bank, Research Division Matthew Miksic - Barclays Bank PLC, Research Division Presentation Operator Good day, and welcome to InMode's Third Quarter 2025 Earnings Results Conference Call.

prnewswire.com

InMode Reports Third Quarter 2025 Financial Results: Quarterly Revenue of $93.2 Million, 78% Gross Margins

YOKNEAM, Israel, Nov. 5, 2025 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial results for the third quarter ended September 30, 2025.

prnewswire.com

InMode Appoints Michael Dennison as President of North America

IRVINE, Calif. , Nov. 3, 2025 /PRNewswire/ -- InMode Ltd.

prnewswire.com

InMode to Participate in Upcoming Investor Conferences

YOKNEAM, Israel , Oct. 30, 2025 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced the participation in the following investor conferences in November: UBS Global Healthcare Conference Presenter: Yair Malca, Chief Financial Officer Format: In-person one-on-one meetings Location: Palm Beach Gardens, FL When: Monday, November 10 Jefferies Global Healthcare Conference Presenter: Moshe Mizrahy, Chief Executive Officer Format: In-person fireside chat moderated by Matt Taylor, Senior Equity Analyst, and one-on-one meetings Location: London, U.K. When: Tuesday, November 18, Fireside Chat at 4:00 pm GMT A live webcast of the presentation can be accessed here.

Loading news...

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance